| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00059-016-4474-9 |
| P698 | PubMed publication ID | 27586137 |
| P2093 | author name string | K Werdan | |
| P2860 | cites work | Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda | Q21203732 |
| Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis | Q24603109 | ||
| beta Blockade after myocardial infarction: systematic review and meta regression analysis | Q24621730 | ||
| Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials | Q24645391 | ||
| Pleiotropic effects of statins | Q24647863 | ||
| Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies | Q24658205 | ||
| Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences | Q26864195 | ||
| Drug-eluting stents or coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of four randomized trials and seventeen observational studies | Q27008267 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases | Q28182631 | ||
| Warfarin, aspirin, or both after myocardial infarction | Q28193836 | ||
| Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials | Q28218081 | ||
| Angiotensin-neprilysin inhibition versus enalapril in heart failure | Q28247091 | ||
| Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials | Q28260825 | ||
| Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials | Q28272636 | ||
| Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study | Q28291971 | ||
| Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era | Q28303142 | ||
| Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Q29547856 | ||
| EuroQol--a new facility for the measurement of health-related quality of life | Q29547873 | ||
| Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials | Q29617910 | ||
| Effectiveness of Ivabradine Treatment in Different Subpopulations with Stable Angina in Clinical Practice: A Pooled Analysis of Observational Studies | Q30314307 | ||
| Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care. | Q30482606 | ||
| Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data | Q30660247 | ||
| Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis | Q30847905 | ||
| Side effects of using nitrates to treat angina | Q33154151 | ||
| The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: an updated meta-analysis | Q33420117 | ||
| Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief | Q33540954 | ||
| A randomized trial of therapies for type 2 diabetes and coronary artery disease | Q33827504 | ||
| Meta-analysis: diagnostic performance of low-radiation-dose coronary computed tomography angiography | Q33845775 | ||
| Meta-analysis of exercise testing to detect coronary artery disease in women | Q33855244 | ||
| Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. | Q34043472 | ||
| 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres | Q34046881 | ||
| Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. | Q34106712 | ||
| Ruling out coronary artery disease in primary care: development and validation of a simple prediction rule | Q34107880 | ||
| Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure | Q34264682 | ||
| A new system for grading recommendations in evidence based guidelines | Q34332845 | ||
| Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study | Q34334496 | ||
| Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review. | Q34385649 | ||
| Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials | Q34389294 | ||
| Efficacy and safety of alirocumab in reducing lipids and cardiovascular events | Q34467233 | ||
| Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes | Q34479098 | ||
| 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut | Q34527664 | ||
| Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials | Q34550514 | ||
| Optimal medical therapy with or without PCI for stable coronary disease | Q34612445 | ||
| Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial | Q34817043 | ||
| Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease | Q34948400 | ||
| Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial | Q35810820 | ||
| Ruling out coronary heart disease in primary care: external validation of a clinical prediction rule | Q35990679 | ||
| Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it "ok" to discontinue? | Q36087931 | ||
| Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction | Q36094414 | ||
| Coronary-artery bypass surgery in patients with left ventricular dysfunction | Q36152222 | ||
| Comparative effectiveness of revascularization strategies | Q36351313 | ||
| Evaluation of aggressive heart rate reduction in patients with stable angina | Q37055832 | ||
| Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy | Q37078225 | ||
| Resting heart rate and outcomes in patients with cardiovascular disease: where do we currently stand? | Q37233293 | ||
| Beta-blocker use for the stages of heart failure | Q37285564 | ||
| Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris | Q37972132 | ||
| CT coronary angiography vs. invasive coronary angiography in CHD. | Q38005695 | ||
| A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris | Q38046358 | ||
| Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association | Q38190806 | ||
| Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro | Q38242976 | ||
| Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial | Q38400391 | ||
| Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis | Q38648802 | ||
| Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies | Q40273143 | ||
| Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease | Q40331861 | ||
| Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials | Q41341778 | ||
| Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). | Q43943294 | ||
| Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial | Q44284348 | ||
| Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration | Q44618977 | ||
| Prevalence of myocardial infarction and coronary heart disease in adults aged 40-79 years in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1) | Q45334972 | ||
| β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease | Q45777217 | ||
| β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease | Q46042238 | ||
| Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. | Q46231868 | ||
| Sex differences in cardiovascular drug targeting | Q46328598 | ||
| Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure | Q46490259 | ||
| Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease | Q46820470 | ||
| Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients | Q47432715 | ||
| Beta-blockers in asymptomatic coronary artery disease: no benefit or no evidence? | Q47744711 | ||
| Ivabradine in stable coronary artery disease without clinical heart failure. | Q53262277 | ||
| Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis. | Q53340933 | ||
| 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu | Q53460540 | ||
| The impact of revascularization on mortality in patients with nonacute coronary artery disease. | Q54237854 | ||
| Lowering LDL Cholesterol Is Good, but How and in Whom? | Q55950956 | ||
| ACC/AHA 2002 guideline update for exercise testing: summary article | Q56765295 | ||
| 2013 ESC guidelines on the management of stable coronary artery disease | Q57243329 | ||
| Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Prevention of Spontaneous Myocardial Infarction in Subjects With Stable Ischemic Heart Disease | Q57787005 | ||
| Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial† | Q58009187 | ||
| Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease | Q61651378 | ||
| Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study | Q84106395 | ||
| Concomitant use of platelet aggregation inhibitors and proton pump inhibitors (PPIs): Position paper of the German Society for Digestive and Metabolic Diseases (DGVS) and the German Society of Cardiology (DGK) | Q85026364 | ||
| Proof That Lower Is Better--LDL Cholesterol and IMPROVE-IT | Q85287731 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | German | Q188 |
| P304 | page(s) | 537-560 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Herz | Q2143725 |
| P1476 | title | National disease management guidelines (NVL) for chronic CAD : What is new, what is particularly important? | |
| P478 | volume | 41 |
Search more.